ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Otolaryngology

Top Otolaryngology Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PHILIP LIU MD

Otolaryngology

3,293

$217K

741
591 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $57

SUMAN GOLLA MD

Otolaryngology

2,342

$83.3K

597
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $57

THOMAS BORAN MD

Otolaryngology

2,100

$123K

554
467 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $57

FRANCES MARCHANT MD

Otolaryngology

2,087

$159K

599
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 22%

$76
Average prescription price

Avg: $57

MAHMOUD GHADERI DO

Otolaryngology

1,998

$104K

483
335 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $57

MATHEW NAGORSKY MD

Otolaryngology

1,945

$137K

460
347 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 22%

$71
Average prescription price

Avg: $57

ANTHONY OLIVERIO M.D.

Otolaryngology

1,825

$90.6K

561
407 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $57

MICHAEL BELL MD

Otolaryngology

1,630

$148K

311
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 22%

$91
Average prescription price

Avg: $57

JOSEPH PUZZI MD

Otolaryngology

1,519

$84.4K

354
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $57

TODD MOREHOUSE DO

Otolaryngology

1,507

$78.3K

401
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $57

JOHN STRAKA MD

Otolaryngology

1,499

$90.9K

490
409 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $57

GEORGE SCHEIN MD

Otolaryngology

1,483

$41.9K

500
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 22%

$28
Average prescription price

Avg: $57

PAUL SCOLIERI MD

Otolaryngology

1,396

$90K

456
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $57

BRAD MILLMAN MD

Otolaryngology

1,358

$87.6K

583
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $57

BRENT YODER M.D.

Otolaryngology

1,189

$58K

327
254 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $57

JEFFREY BUCKWALTER MD

Otolaryngology

1,187

$51.2K

236
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $57

JOHN FEEHERY MD

Otolaryngology

1,173

$95.3K

318
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 22%

$81
Average prescription price

Avg: $57

WILLIAM BRUCE MD

Otolaryngology

1,148

$51.6K

375
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $57

WAYNE ZIMMER MD

Otolaryngology

1,136

$41.7K

362
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $57

SHELLY MCQUONE MD

Otolaryngology

1,130

$61.2K

283
221 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $57

KHALID MAHMOOD M.D.

Otolaryngology

1,124

$116K

96
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 22%

$103
Average prescription price

Avg: $57

ERICA THALER MD

Otolaryngology

1,100

$68.6K

235
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $57

MARC MASLOV M.D.

Otolaryngology

1,066

$60.7K

332
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $57

JOSEPH SPIEGEL M.D.

Otolaryngology

992

$93.4K

251
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 22%

$94
Average prescription price

Avg: $57

STEPHEN FROMAN MD

Otolaryngology

991

$93.5K

367
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 22%

$94
Average prescription price

Avg: $57

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank